{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:15:42Z","timestamp":1763705742907,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.diabres.2020.108026","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T11:22:48Z","timestamp":1579173768000},"page":"108026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Insulin pumps use in Greece: Efficacy and safety data from 140 patients with type 1 diabetes mellitus"],"prefix":"10.1016","volume":"160","author":[{"given":"Maria","family":"Somali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zadalla","family":"Mouslech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2020.108026_b0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0161-6420(95)30973-6","article-title":"Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial","volume":"102","author":"Diabetes Control and Complications Trial Research Group (DCCT)","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.diabres.2020.108026_b0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2020.108026_b0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/diacare.18.3.361","article-title":"Implementation of treatment protocols in the Diabetes Control and Complications Trial","volume":"18","author":"Diabetes Control and Complications Trial Research Group","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2020.108026_b0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1464-5491.2005.01738.x","article-title":"Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial","volume":"26","author":"Hoogma","year":"2006","journal-title":"Diab Med"},{"key":"10.1016\/j.diabres.2020.108026_b0025","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/diacare.25.11.2074","article-title":"A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycaemic control","volume":"25","author":"DeVries","year":"2002","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2020.108026_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.324.7339.705","article-title":"Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomized controlled trials","volume":"324","author":"Pickup","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2020.108026_b0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2337\/diacare.26.4.1079","article-title":"Insulin pump therapy: a meta-analysis","volume":"26","author":"Weissberg-Benchell","year":"2003","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2020.108026_b0040","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00125-004-1545-x","article-title":"Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy","volume":"47","author":"Siebenhofer","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2020.108026_b0045","first-page":"1779","article-title":"Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes","volume":"22","author":"Boland","year":"1999","journal-title":"DiabetesCare"},{"key":"10.1016\/j.diabres.2020.108026_b0050","first-page":"324","article-title":"Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes","volume":"19","author":"Bode","year":"1996","journal-title":"DiabetesCare"},{"key":"10.1016\/j.diabres.2020.108026_b0055","first-page":"746","article-title":"Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years","volume":"19","author":"Linkeschova","year":"2002","journal-title":"DiabetMed"},{"key":"10.1016\/j.diabres.2020.108026_b0060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.112.3.559","article-title":"Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial","volume":"112","author":"Weintrob","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.diabres.2020.108026_b0065","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1464-5491.2002.00713.x","article-title":"Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years","volume":"19","author":"Linkeschova","year":"2002","journal-title":"Diab Med"},{"key":"10.1016\/j.diabres.2020.108026_b0070","first-page":"49","article-title":"Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump","volume":"7","author":"Schiffers","year":"1997","journal-title":"Psychother Psychosom Med Psychol"},{"key":"10.1016\/j.diabres.2020.108026_b0075","first-page":"143","article-title":"International survey of insulin pump users: Impact of continuous subcutaneous insulin infusion therapy on glucose control and quality of life","volume":"1","author":"Hammond","year":"2007","journal-title":"PrimaryCareDiabetes"},{"key":"10.1016\/j.diabres.2020.108026_b0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/135581969700200105","article-title":"Development and Testing of the UK SF-12 (short form health survey)","volume":"2","author":"Jenkinson","year":"1997","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.diabres.2020.108026_b0085","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group.Reliability and validity of a diabetes quality-of-life measure for theDiabetes Control and Complications Trial (DCCT). DiabetesCare1988; 11: 725\u201332.","DOI":"10.2337\/diacare.11.9.725"},{"issue":"2","key":"10.1016\/j.diabres.2020.108026_b0090","first-page":"132","article-title":"Insulin-pump use in everyday practice: Data from an exhaustive regional registry in France","volume":"34","author":"Riveline","year":"2008","journal-title":"Diabetes&Metabolism"},{"issue":"Supp D","key":"10.1016\/j.diabres.2020.108026_b0095","article-title":"Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections","volume":"29","author":"Bode","year":"2007","journal-title":"ClinTherapeutics"},{"issue":"5","key":"10.1016\/j.diabres.2020.108026_b0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajog.2007.03.062","article-title":"Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials","volume":"197","author":"Mukhopadhyay","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.diabres.2020.108026_bib106","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2015.0309","article-title":"The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study","author":"Melidonis","year":"2016","journal-title":"Diabetes Technol Ther"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719316201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719316201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:11:10Z","timestamp":1759173070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822719316201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":21,"alternative-id":["S0168822719316201"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108026","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin pumps use in Greece: Efficacy and safety data from 140 patients with type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2020.108026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108026"}}